Other OTC - Delayed Quote USD

hVIVO plc (OPORF)

0.3500 0.0000 (0.00%)
At close: April 4 at 1:26 PM EDT
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
56,043.0000
56,043.0000
48,477.0000
36,864.0000
20,602.0000
Cost of Revenue
24,170.0000
--
--
963.0000
727.0000
Gross Profit
31,873.0000
--
--
35,901.0000
19,875.0000
Operating Expense
45,722.0000
45,722.0000
42,335.0000
36,568.0000
28,485.0000
Operating Income
10,321.0000
10,321.0000
6,142.0000
296.0000
-8,610.0000
Net Non Operating Interest Income Expense
1,005.0000
1,005.0000
4.0000
-215.0000
-374.0000
Pretax Income
11,147.0000
11,147.0000
-365.0000
277.0000
-10,980.0000
Tax Provision
-4,968.0000
-4,968.0000
411.0000
351.0000
-189.0000
Net Income Common Stockholders
16,115.0000
16,115.0000
-776.0000
-74.0000
-10,791.0000
Diluted NI Available to Com Stockholders
16,115.0000
16,115.0000
-776.0000
-74.0000
-10,791.0000
Basic EPS
0.00
0.02
-0.00
-0.00
-0.02
Diluted EPS
0.00
0.02
-0.00
-0.00
-0.02
Basic Average Shares
673,017.1900
677,444.1330
670,943.9180
670,187.3130
599,920.2070
Diluted Average Shares
673,017.1900
685,847.3150
670,943.9180
670,187.3130
599,920.2070
Total Operating Income as Reported
10,102.0000
10,102.0000
6,023.0000
590.0000
-10,259.0000
Rent Expense Supplemental
--
--
--
1,399.0000
1,331.0000
Total Expenses
45,722.0000
45,722.0000
42,335.0000
36,568.0000
29,212.0000
Net Income from Continuing & Discontinued Operation
16,115.0000
16,115.0000
-776.0000
-74.0000
-10,791.0000
Normalized Income
16,292.3900
16,292.3900
4,955.5600
-290.2700
-8,934.5156
Interest Income
1,181.0000
1,181.0000
136.0000
12.0000
--
Interest Expense
155.0000
155.0000
133.0000
227.0000
374.0000
Net Interest Income
1,005.0000
1,005.0000
4.0000
-215.0000
-374.0000
EBIT
11,302.0000
11,302.0000
-232.0000
504.0000
-10,606.0000
EBITDA
14,018.0000
14,018.0000
2,698.0000
3,069.0000
-8,554.0000
Reconciled Cost of Revenue
24,170.0000
--
--
963.0000
727.0000
Reconciled Depreciation
2,716.0000
2,716.0000
2,930.0000
2,565.0000
2,052.0000
Net Income from Continuing Operation Net Minority Interest
16,115.0000
16,115.0000
-776.0000
-74.0000
-10,791.0000
Total Unusual Items Excluding Goodwill
-219.0000
-219.0000
-7,076.0000
267.0000
-1,889.0000
Total Unusual Items
-219.0000
-219.0000
-7,076.0000
267.0000
-1,889.0000
Normalized EBITDA
14,237.0000
14,237.0000
9,774.0000
2,802.0000
-6,665.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0000
Tax Effect of Unusual Items
-41.6100
-41.6100
-1,344.4400
50.7300
-32.5156
12/31/2020 - 6/5/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MNPR Monopar Therapeutics Inc.
0.6582
+4.81%
 
SVRA Savara Inc.
4.4100
-0.90%
 
SEEL Seelos Therapeutics, Inc.
0.2910
+1.89%
 
MLEC Moolec Science SA
1.4500
+2.11%
 
PALI Palisade Bio, Inc.
6.05
-2.89%
 
BPTH Bio-Path Holdings, Inc.
2.6800
+1.71%
 
JAGX Jaguar Health, Inc.
0.1800
+5.88%